LeonaBio (LONA) Short-term Investments (2020 - 2026)

LeonaBio (LONA) has reported Short-term Investments for 7 consecutive years, with $34.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments rose 240.03% year-over-year to $34.8 million; the TTM figure through Mar 2026 stood at $34.8 million (up 240.03% YoY), while the FY2025 annual figure was $19.1 million, up 571.66% from the prior year.
• Short-term Investments climbed to $34.8 million in Q1 2026 per LONA's latest filing, from $19.1 million in the prior quarter.
• Across five years, Short-term Investments topped out at $157.3 million in Q2 2022 and bottomed at $2.8 million in Q4 2024.
• Historically, Short-term Investments has averaged $56.3 million across 5 years, with a median of $44.3 million in 2024.
• Annual changes were most pronounced in 2024 — Short-term Investments tumbled 95.01% — and 2025, when it jumped 571.66%.
• LeonaBio's Short-term Investments stood at $104.4 million in 2022, then sank by 45.55% to $56.8 million in 2023, then sank by 95.01% to $2.8 million in 2024, then surged by 571.66% to $19.1 million in 2025, then soared by 82.87% to $34.8 million in 2026.
• Business Quant data shows LONA's Short-term Investments at $34.8 million in Q1 2026, $19.1 million in Q4 2025, and $4.4 million in Q3 2025.